Unichem Laboratories Ltd
Records under this name other than the patents Unichem Laboratories Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Back to Unichem Laboratories Ltd
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,331,283 | Pharmaceutical compositions comprising cinacalcet hydrochloride and one or more binders Lapsed on the fee record Ended May 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 17, 2026 | From the USPTO record |
| US 9,951,012 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine Lapsed on the fee record Ended Apr 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | From the USPTO record |
| US 9,908,881 | Process for the preparation of apixaban and intermediates thereof Lapsed on the fee record Ended Mar 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2026 | From the USPTO record |
| US 9,902,717 | Process of preparing potassium salt of Azilsartan medoxomil Lapsed on the fee record Ended Feb 27, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 27, 2026 | From the USPTO record |
| US 8,338,638 | Antimicrobial derivatives of anacardic acid and process for preparing the same Lapsed on the fee record Ended Dec 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2024 | From the USPTO record |
| US 10,829,450 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine Lapsed on the fee record Ended Nov 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2024 | From the USPTO record |
| US 10,414,720 | Process for the preparation of lacosamide Lapsed on the fee record Ended Sep 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2023 | From the USPTO record |
| US 10,336,753 | Process for the preparation of apixaban and intermediates thereof Lapsed on the fee record Ended Jul 2, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2023 | From the USPTO record |
| US 10,266,507 | Process for the preparation of ranolazine Lapsed on the fee record Ended Apr 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2023 | From the USPTO record |
| US 10,034,882 | Tofacitinib orally disintegrating tablets Lapsed on the fee record Ended Jul 31, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 31, 2022 | From the USPTO record |